Laboratorios Argenol, trying to provide alternatives to COVID19, has analyzed the efficacy of its products, verifying that the silver-based SSB and SCS compounds reduce the viral load against Vaccinia virus more than 99.95%. This result covers all encapsulated viruses, including all coronaviruses (eg. SARS-CoV-2 causing COVID19 disease).
Furthermore, Argenol presents a hydroalcoholic formulation based on SSB, a really effective hand sanitizer preventing contamination for a longer period of time thanks to the distinctive remaining effect of silver.
We take our products to the Asian market
From 31 October to 1 November 2018, we will attend the fair "In cosmetics · Asia" to be held in Bangkok and which brings together leading companies in the manufacture of active principles for the cosmetics industry.Featured News Contact(+34) 976 33 62 66(+34) 976 53...
Laboratorios Argenol at CPhI Worldwide
Our laboratory will attend the most important fair of the pharmaceutical compound industry from 9-11 October 2018.Featured NewsContact(+34) 976 33 62 66(+34) 976 53 36 email@example.comAutovía de Logroño Km 7,4Pol. Ind. Europa 2, nave 150011...
Argenol joins the Club Cámara Internacional
Laboratorios Argenol, manufacturer of active pharmaceutical principles derived from silver, has just joined the Club Cámara Internacional. Ivana Ascaso, managing director of the firm, and Pilar Enguita, Head of National Sales, visited the editorial space.Featured News...
(+34) 976 53 36 59
Autovía de Logroño Km 7,4
Pol. Ind. Europa 2, nave 1
50011 Zaragoza (Spain)
Autovía de Logroño Km 18
Pol. Ind. Los Leones, naves 22-23
50298 Pinseque - Zaragoza (Spain)